Sigilon Therapeutics Inc's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sigilon Therapeutics Inc's ROI in the second quarter of 2023?
Sigilon Therapeutics Inc recorded a cumulative net loss of $-30 million during 12 months ending in the second quarter of 2023, resulting in a negative return on investment (ROI) of -61.01%.

Within the Healthcare sector 722 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2023 from 4176 to 4560.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Investment Change TTM	-49.89 %	-47.75 %	-47.78 %	-44.36 %	-17.97 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	30	48	56	64	74
Return On Investment (TTM)	-61.01 %	-61.28 %	-61.45 %	-64.88 %	-66.84 %
SGTX's Overall Ranking	# 4560	# 4176	# 4353	# 0	# 0
Seq. Investment Change TTM	-18.09 %	-14.64 %	-15.8 %	-14.88 %	-14.6 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-30	-37	-44	-55	-66

SGTX Company Profile >> Back to SGTX Roi Comparisons >> See Annual SGTX Return On Investment

Return On Investment SGTX's Ranking
Within:	No.
Industry	# 321
Sector	# 723
Overall	# 4560

Return On Investment Statistics
High	Average	Low
-44.93 %	-59.96 %	-66.84 %
(Mar 31 2021)		(Jun 30 2022)

Financial Statements
Sigilon Therapeutics Inc's II. Quarter Investments	$ 30 Millions	SGTX's Balance sheet
Sigilon Therapeutics Inc's II. Quarter Income	$ -8 Millions	Quarterly SGTX's Income Statement
SGTX's Income by Division		See SGTX's Income by Division

SGTX Annual Return On Investment	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	56	109	0	0	0
Y / Y Investment Growth	-48.59 %	-	-	-	-
Net Income in Millions	-44	-77	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-77.39 %	-70.62 %	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SGTX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SGTX's Competitors
Subscribers only: Roi for Sigilon Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for SGTX's Customers

Other Ratios
SGTX's Roa	SGTX's Inventory Turnover Ratio	SGTX's Growth Rates	SGTX's Dividend Statistics
	SGTX's Profitability Ratios	SGTX's Asset Turnover Ratio	SGTX's Dividend Growth
SGTX's Roe	SGTX's Valuation Ratios	SGTX's Financial Strength Ratios	SGTX's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2023, within Healthcare Sector

ROI

Date modified: 2026-09-18T13:11:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.